Ticker: XBI CUSIP: 78464A870 Class: S&P BIOTECH
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q3 2024 | 187,900 | $18,565 | — | — |
| Q2 2024 | 968,300 | $89,771 | — | — |
| Q1 2024 | 606,000 | $57,503 | — | — |
| Q4 2023 | 271,100 | $24,207 | — | — |
| Q3 2023 | 336,500 | $24,571 | — | — |
| Q2 2023 | 30,400 | $2,529 | — | — |
| Q1 2023 | 1,741,900 | $132,750 | — | — |
| Q4 2022 | 953,200 | $79,116 | — | — |
| Q3 2022 | 1,329,800 | $105,480 | — | — |
| Q1 2022 | 201,000 | $18,066 | — | — |
| Q4 2021 | 531,600 | $59,518 | — | — |
| Q1 2021 | 88,100 | $11,951 | — | — |
| Q2 2020 | 82,000 | $9,180 | — | — |
| Q1 2020 | 456,600 | $35,359 | — | — |
| Q4 2019 | 849,100 | $80,758 | — | — |
| Q3 2019 | 521,900 | $39,795 | — | — |
| Q2 2019 | 1,043,300 | $91,508 | — | — |
| Q1 2019 | 299,800 | $27,144 | — | — |
| Q4 2018 | 3,200 | $230 | — | — |